Technological Know-How of Leading Life Science Intermediates Companies 2014
This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies. The report presents:
Contains 35 pages
- Internally developed and acquired technologies, and related capabilities.
- Proprietary technologies and patent litigations.
Contains 35 pages
1. BASF
2. CAMBREX
3. CLARIANT
4. DOWPHARMA
5. DSM
6. EVONIK
7. LANXESS
8. LONZA
9. NOVASEP
10. RHODIA
FOR EACH COMPANY, THE REPORT PRESENTS:
Internally developed and acquired technologies, and related capabilities.
Proprietary technologies and patent litigations.
2. CAMBREX
3. CLARIANT
4. DOWPHARMA
5. DSM
6. EVONIK
7. LANXESS
8. LONZA
9. NOVASEP
10. RHODIA
FOR EACH COMPANY, THE REPORT PRESENTS:
Internally developed and acquired technologies, and related capabilities.
Proprietary technologies and patent litigations.
More Publications
The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs
US$ 1,480.00
October 2010
32 pages
Technological Know-How of Leading Computer Tomagraphy (CT) Companies
US$ 1,480.00
June 2012
60 pages
Technological Know-How of Leading X-Ray Equipment Companies
US$ 1,480.00
June 2012
60 pages
The 2011 Leading Life Science Intermediates Companies Financial Analyses
US$ 1,480.00
October 2010
105 pages
The 2011 Leading Life Science Intermediates Companies Product Portfolio Analyses
US$ 1,480.00
October 2010
57 pages
